
Abstract 3936: A branching evolution model at relapse characterizes multiple myeloma patients who responded to upfront combination therapy including new drugs
Author(s) -
Carolina Terragna,
Marina Martello,
Barbara Santacroce,
Vincenza Solli,
Lucia Pantani,
Elena Zamagni,
Paola Tacchetti,
Beatrice Anna Zannetti,
Katia Mancuso,
Giulia Marzocchi,
Nicoletta Testoni,
Gaia Ameli,
Rosalinda Termini,
Angela Flores Dico,
Enrica Borsi,
Giovanni Martinelli,
Michèle Cavo
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-3936
Subject(s) - multiple myeloma , carfilzomib , medicine , oncology , disease , proteasome inhibitor